Skip to content
Subscriber Only

Theranos Expands Scientific Board; CEO Says Data Will Be Shared

  • Blood-testing startup adds medical professors as advisers
  • CEO Holmes says company is preparing manuscripts to publish

Theranos Inc., the blood-testing startup facing regulatory scrutiny, added physicians from prominent hospitals to its scientific and medical advisory board in a push to help persuade skeptics that the secretive company’s technology is viable.

Chief Executive Officer Elizabeth Holmes said the medical board is advising the company as it seeks to become more transparent about how its technology works. Theranos has said it can run a number of tests on just one fingerprick’s worth of blood, at a fraction of the price charged by big laboratory companies like Quest Diagnostics Inc. and Laboratory Corp. of America Holdings.